Investigate the Effect of AZD1305 on Patients With Left Ventricular Dysfunction

NCT00748982 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Left Ventricle Function

Interventions

DRUG: AZD1305
DRUG: Placebo

Sponsor

AstraZeneca